A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders

NCT06745518 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperphosphatemia Patients on Hemodialysis

Interventions

DRUG: TS-172
DRUG: Placebo

Sponsor

Taisho Pharmaceutical Co., Ltd.